Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 60

1.

Synthetic Aβ peptides acquire prion-like properties in the brain.

Xiao X, Cali I, Yuan J, Cracco L, Curtiss P, Zeng L, Abouelsaad M, Gazgalis D, Wang GX, Kong Q, Fujioka H, Puoti G, Zou WQ.

Oncotarget. 2015 Jan 20;6(2):642-50.

2.

Comparative Study of Prions in Iatrogenic and Sporadic Creutzfeldt-Jakob Disease.

Xiao X, Yuan J, Qing L, Cali I, Mikol J, Delisle MB, Uro-Coste E, Zeng L, Abouelsaad M, Gazgalis D, Martinez MC, Wang GX, Brown P, Ironside JW, Gambetti P, Kong Q, Zou WQ.

J Clin Cell Immunol. 2014 Aug;5(4). pii: 240.

3.

Prevalence and associated factors of corneal blindness in Ningxia in northwest China.

Sheng XL, Li HP, Liu QX, Rong WN, Du WZ, Ma L, Yan GH, Ma RQ, Zhang JL, Xu HF, Zou WQ, Bi XJ.

Int J Ophthalmol. 2014 Jun 18;7(3):557-62. doi: 10.3980/j.issn.2222-3959.2014.03.30. eCollection 2014.

4.

Concurrent variably protease-sensitive prionopathy and amyotrophic lateral sclerosis.

Cannon A, Bieniek KF, Lin WL, Notari S, Zou WQ, Gambetti P, Pedraza O, Graff-Radford NR, Ferman TJ, Dickson DW.

Acta Neuropathol. 2014 Aug;128(2):313-5. doi: 10.1007/s00401-014-1309-8. Epub 2014 Jun 14. No abstract available.

PMID:
24928712
5.

Application of computed tomography for differential diagnosis of glioma stoke and simple cerebral hemorrhage.

Li XL, Zhou FM, Shangguan SQ, Zou WQ, Deng YQ, Chen T, Chen GH.

Asian Pac J Cancer Prev. 2014;15(8):3425-8.

6.

Variably Protease-sensitive Prionopathy in an Apparent Cognitively Normal 93-Year-Old.

Ghoshal N, Perry A, McKeel D, Schmidt RE, Carter D, Norton J, Zou WQ, Xiao X, Puoti G, Notari S, Gambetti P, Morris JC, Cairns NJ.

Alzheimer Dis Assoc Disord. 2015 Apr-Jun;29(2):173-6. doi: 10.1097/WAD.0000000000000049. No abstract available.

PMID:
24845762
7.

Recombinant human prion protein inhibits prion propagation in vitro.

Yuan J, Zhan YA, Abskharon R, Xiao X, Martinez MC, Zhou X, Kneale G, Mikol J, Lehmann S, Surewicz WK, Castilla J, Steyaert J, Zhang S, Kong Q, Petersen RB, Wohlkonig A, Zou WQ.

Sci Rep. 2013 Oct 9;3:2911. doi: 10.1038/srep02911.

8.

Small ruminant nor98 prions share biochemical features with human gerstmann-sträussler-scheinker disease and variably protease-sensitive prionopathy.

Pirisinu L, Nonno R, Esposito E, Benestad SL, Gambetti P, Agrimi U, Zou WQ.

PLoS One. 2013 Jun 24;8(6):e66405. doi: 10.1371/journal.pone.0066405. Print 2013.

9.

Glycoform-selective prion formation in sporadic and familial forms of prion disease.

Xiao X, Yuan J, Haïk S, Cali I, Zhan Y, Moudjou M, Li B, Laplanche JL, Laude H, Langeveld J, Gambetti P, Kitamoto T, Kong Q, Brandel JP, Cobb BA, Petersen RB, Zou WQ.

PLoS One. 2013;8(3):e58786. doi: 10.1371/journal.pone.0058786. Epub 2013 Mar 19.

10.

Protease-sensitive prions with 144-bp insertion mutations.

Xiao X, Cali I, Dong Z, Puoti G, Yuan J, Qing L, Wang H, Kong Q, Gambetti P, Zou WQ.

Aging (Albany NY). 2013 Mar;5(3):155-73.

11.

Prions in variably protease-sensitive prionopathy: an update.

Zou WQ, Gambetti P, Xiao X, Yuan J, Langeveld J, Pirisinu L.

Pathogens. 2013 Jul 5;2(3):457-71. doi: 10.3390/pathogens2030457. Review.

12.

Isolation of soluble and insoluble PrP oligomers in the normal human brain.

Xiao X, Yuan J, Zou WQ.

J Vis Exp. 2012 Oct 3;(68). pii: 3788. doi: 10.3791/3788.

13.

Sporadic fatal insomnia with clinical, laboratory, and genetic findings.

Luo JJ, Truant AL, Kong Q, Zou WQ.

J Clin Neurosci. 2012 Aug;19(8):1188-92. doi: 10.1016/j.jocn.2011.11.023. Epub 2012 Jun 18.

PMID:
22717776
14.

Creutzfeldt-Jakob disease with unusually extensive neuropathology in a child treated with native human growth hormone.

Mikol J, Deslys JP, Zou WQ, Xiao W, Brown P, Budka H, Goutieres F.

Clin Neuropathol. 2012 May-Jun;31(3):127-34.

15.

Cellular prion protein is essential for oligomeric amyloid-β-induced neuronal cell death.

Kudo W, Lee HP, Zou WQ, Wang X, Perry G, Zhu X, Smith MA, Petersen RB, Lee HG.

Hum Mol Genet. 2012 Mar 1;21(5):1138-44. doi: 10.1093/hmg/ddr542. Epub 2011 Nov 18.

16.

Alkylating antitumor drug mechlorethamine conceals a structured PrP domain and inhibits in vitro prion amplification.

Zhou X, Bi H, Wong J, Shimoji M, Wang Y, Yuan J, Xiao X, Wang GX, Zou WQ.

J Toxicol Environ Health A. 2011;74(22-24):1493-503. doi: 10.1080/15287394.2011.618978.

PMID:
22043910
17.

Sporadic fatal insomnia in a young woman: a diagnostic challenge: case report.

Moody KM, Schonberger LB, Maddox RA, Zou WQ, Cracco L, Cali I.

BMC Neurol. 2011 Oct 31;11:136. doi: 10.1186/1471-2377-11-136.

18.

Characterization of spontaneously generated prion-like conformers in cultured cells.

Zou RS, Fujioka H, Guo JP, Xiao X, Shimoji M, Kong C, Chen C, Tasnadi M, Voma C, Yuan J, Moudjou M, Laude H, Petersen RB, Zou WQ.

Aging (Albany NY). 2011 Oct;3(10):968-84.

19.

Pulling rabbits to reveal the secrets of the prion protein.

Fernandez-Funez P, Zhang Y, Sanchez-Garcia J, Jensen K, Zou WQ, Rincon-Limas DE.

Commun Integr Biol. 2011 May;4(3):262-6. doi: 10.4161/cib.4.3.15054. Epub 2011 May 1.

20.

Insoluble cellular prion protein and its association with prion and Alzheimer diseases.

Zou WQ, Zhou X, Yuan J, Xiao X.

Prion. 2011 Jul-Sep;5(3):172-8. doi: 10.4161/pri.5.3.16894. Epub 2011 Jul 1. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk